Pharmacy Week in Review: December 1, 2017

Most Popular

Related Articles

Pharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.
Excelera has announced the appointment of Lorrie A. Carr as its new CEO. Ms. Carr succeeds Jim Fox who retired effective April 2.
New and emerging therapies have demonstrated significant efficacy in the treatment and management of moderate to severe plaque psoriasis. This educational session will discuss the advancing therapeutic landscape of plaque psoriasis and the clinical efficacy and safety profiles of newer biologic agents indicated for the treatment of psoriasis. Identifying the most appropriate patients with plaque psoriasis for the new therapies and the role of specialty pharmacists to optimize pharmacologic treatment and therapy adherence in psoriasis care will be explained.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$